Innovations and challenges in bioresponsive materials for effective drug delivery in diabetes mellitus

Abstract

Bioresponsive materials have gained prominence as innovative tools for advancing drug delivery systems, particularly in managing type 1 and type 2 diabetes mellitus. These materials respond to biological stimuli such as pH, glucose, enzymes, or temperature, thereby enabling spatiotemporally controlled drug release. This review examines recent progress in the design strategies, activation mechanisms, and therapeutic applications of these materials in diabetes care. Key focus areas include macromolecular insulin delivery systems and oral hypoglycemic agents, with emphasis on their efficacy in regulating blood glucose homeostasis. Despite their promise, challenges persist in translating these technologies to clinical practice, including scalability limitations, insufficient clinical validation, regulatory hurdles, and healthcare system compatibility. Current therapeutic shortcomings, such as frequent injections and adverse effects compromising patient adherence, are discussed. By synthesizing contemporary research developments and implementation barriers, this work provides critical insights into optimizing bioresponsive platforms for clinical translation. Our analysis underscores the need for interdisciplinary approaches to address technical and practical constraints, and ultimately engineer patient-centric, scalable solutions that enhance therapeutic outcomes and quality of life. Future directions include bridging material innovation with clinical needs to develop next-generation diabetes management systems.

Keywords

Bioresponsive / biomaterials / drug delivery / glucose / diabetes

References

[1] Magliano D, Boyko EJ: IDF Diabetes Atlas . 10th edition. Brussels: International Diabetes Federation; 2021.

[2] Alldredge BK, Corelli RL, Ernst ME, Guglielmo BJ, Jacobson PA, Kradjan WA, et al.: Koda-Kimble and Young’s Applied Therapeutics - The Clinical Use of Drugs . 10th edition. USA: Lippincott Williams & Wilkins; 2013.

[3] Blumer I: Severe, Delayed Insulin Detemir Injection Site Reaction. Diabetic Medicine 2008, 25: 1008.

[4] Neel N, Ghobara Y, Turkmani M: Liraglutide-induced Injection Site Reaction. Journal of Dermatology and Dermatologic Surgery 2019, 23: 97-98.

[5] Jain KK: An Overview of Drug Delivery Systems. In Drug Delivery Systems . Edited by Jain KK . New York, NY: Springer New York; 2008: 1-54.

[6] Devarajan PV, Jain S (Eds): Targeted Drug Delivery: Concepts and Design . Cham: Springer International Publishing; 2015.

[7] Grumezescu AM: Nanobiomaterials in Drug Delivery: Applications of Nanobiomaterials . Kidlington, Oxford, UK: William Andrew is an imprint of Elsevier; 2016.

[8] Ulijn RV, Bibi N, Jayawarna V, Thornton PD, Todd SJ, Mart RJ, et al.: Bioresponsive Hydrogels. Materials Today 2007, 10: 40-48.

[9] Singh P, Carrier A, Chen Y, Lin S, Wang J, Cui S, et al.: Polymeric Microneedles for Controlled Transdermal Drug Delivery. Journal of Controlled Release 2019, 315: 97-113.

[10] Alavi SE, Alharthi S, Alavi SZ, Raza A, Shahmabadi HE: Bioresponsive Drug Delivery Systems. Drug Discovery Today 2024, 29: 103849.

[11] Gupta P, Vermani K, Garg S: Hydrogels: From Controlled Release to pH-responsive Drug Delivery. Drug Discov Today 2002, 7: 569-579.

[12] Zhang Y, Li P, Pan H, Liu L, Ji M, Sheng N, et al.: Retinal-conjugated pH-sensitive Micelles Induce Tumor Senescence for Boosting Breast Cancer Chemotherapy. Biomaterials 2016, 83: 219-232.

[13] Bae Y, Jang W-D, Nishiyama N, Fukushima S, Kataoka K: Multifunctional Polymeric Micelles with Folate-mediated Cancer Cell Targeting and pH-Triggered Drug Releasing Properties for Active Intracellular Drug Delivery. Molecular BioSystems 2005, 1: 242-250.

[14] Guo WX, Hu LF, Feng YH, Chen BZ, Guo XD: Advances in Self-assembling of pH-sensitive Polymers: A Mini Review on Dissipative Particle Dynamics. Colloids and Surfaces B: Biointerfaces 2022, 210: 112202.

[15] Al-Shaeli M, Benkhaya S, Al-Juboori RA, Koyuncu I, Vatanpour V: pH-responsive Membranes: Mechanisms, Fabrications, and Applications. Science of the Total Environment 2024, 946: 173865.

[16] Chen Y, Sun P: pH-Sensitive Polyampholyte Microgels of Poly(Acrylic Acid- co-Vinylamine) as Injectable Hydrogel for Controlled Drug Release . Polymers 2019, 11: 285.

[17] Shim WS, Kim SW, Lee DS: Sulfonamide-Based pH- and Temperature-Sensitive Biodegradable Block Copolymer Hydrogels. Biomacromolecules 2006, 7: 1935-1941.

[18] Bae YH, Park SY: PH-Sensitive Polymer Containing Sulfonamide and Its Synthesis Method. US6103865A; 2020 [https://patents.google.com/patent/US6103865A/en] Accessed on date 20 September 2024.

[19] Abka-khajouei R, Tounsi L, Shahabi N, Patel AK, Abdelkafi S, Michaud P . Structures, Properties and Applications of Alginates. marine drugs 2022, 20: 364. https://doi.org/10.3390/md20060364.

[20] Wardhani DH, Aryanti N, Aziz A, Firdhaus RA, Ulya HN . Ultrasonic degradation of alginate: A matrix for iron encapsulation using gelation. Food Bioscience 2021, 41: 100803.

[21] Guo S, Li H: Chitosan-Derived Nanocarrier Polymers for Drug Delivery and pH-Controlled Release in Type 2 Diabetes Treatment. Journal of Fluorescence 2024. https://doi.org/10.1007/s10895-024-03810-w.

[22] Bhosale RR, Gangadharappa HV, Osmani RAM, Gowda DV: Design and Development of Polymethylmethacrylate-grafted Gellan Gum (PMMA-g-GG)-based pH-sensitive Novel Drug Delivery System for Antidiabetic Therapy. Drug Delivery and Translational Research 2020, 10: 1002-1018.

[23] Trinh TA, Le TMD, Nguyen HT, Nguyen TL, Kim J, Huynh DP, et al.: pH-Temperature Responsive Hydrogel-Mediated Delivery of Exendin-4 Encapsulated Chitosan Nanospheres for Sustained Therapeutic Efficacy in Type 2 Diabetes Mellitus. Macromolecular Bioscience 2023, 23: 2300221.

[24] Ren C, Zhong D, Qi Y, Liu C, Liu X, Chen S, et al.: Bioinspired pH-Responsive Microalgal Hydrogels for Oral Insulin Delivery with Both Hypoglycemic and Insulin Sensitizing Effects. ACS Nano 2023, 17: 14161-14175.

[25] Zhang H, Gu Z, Li W, Guo L, Wang L, Guo L, et al.: pH-sensitive O-carboxymethyl Chitosan/Sodium Alginate Nanohydrogel for Enhanced Oral Delivery of Insulin. International Journal of Biological Macromolecules 2022, 223: 433-445.

[26] Fetouh HA, Aleem EEA, Mohammed NH, Aldesouky JMA, Ismail AM: Formulation of New Drug Delivery Systems for Insulin from Natural Bioactive Biocompatible Polymers. Scientific Reports 2025, 15: 3941.

[27] Hoffman AS: “Intelligent” Polymers in Medicine and Biotechnology. Artificial Organs 1995, 19: 458-467.

[28] Chatterjee S, Hui PC, Kan CW, Wang W: Dual-responsive (pH/Temperature) Pluronic F-127 Hydrogel Drug Delivery System for Textile-based Transdermal Therapy. Scientific Reports 2019, 9: 11658.

[29] Schmaljohann D: Thermo- and pH-Responsive Polymers in Drug Delivery. Advanced Drug Delivery Reviews 2006, 58: 1655-1670.

[30] Gong C, Qi T, Wei X, Qu Y, Wu Q, Luo F, et al.: Thermosensitive Polymeric Hydrogels As Drug Delivery Systems. Current Medicinal Chemistry 2013, 20: 79-94.

[31] Aoki T, Kawashima M, Katono H, Kawashima M, Katono H, Sanui K, et al.: Temperature-Responsive Interpenetrating Polymer Networks Constructed with Poly(acrylic acid) and Poly(N,N-dimethylacrylamide). Macromolecules 1994, 27: 947-952.

[32] Zareie HM, Volga Bulmus E, Gunning AP, Hoffman AS, Piskin E, Morris VJ: Investigation of a Stimuli-responsive Copolymer by Atomic Force Microscopy. Polymer 2000, 41: 6723-6727.

[33] Zhang X-Z, Yang Y-Y, Chung T-S, Ma KX: Preparation and Characterization of Fast Response Macroporous Poly(N-isopropylacrylamide) Hydrogels . Langmuir 2001, 17: 6094-6099.

[34] Dong L, Hoffman AS: A Novel Approach for Preparation of pH-sensitive Hydrogels for Enteric Drug Delivery. Journal of Controlled Release 1991, 15: 141-152.

[35] Khan B, Arbab A, Khan S, Fatima H, Bibi I, Chowdhry NP, et al.: Recent Progress in Thermosensitive Hydrogels and Their Applications in Drug Delivery Area. MedComm - Biomaterials and Applications 2023, 2: 55.

[36] Yao X, Gong Z, Yin W, Li H, Douroumis D, Huang L: Islet Cell Spheroids Produced by a Thermally Sensitive Scaffold: A New Diabetes Treatment. Journal of Nanobiotechnology 2024, 22: 657.

[37] Peña-Juárez MC, Guadarrama-Escobar OR, Escobar-Chávez JJ: Transdermal Delivery Systems for Biomolecules. Journal of Pharmaceutical Innovation 2022, 17: 319-332.

[38] Li JY, Feng YH, He YT, Hu LF, Liang L, Zhao ZQ, et al.: Thermosensitive Hydrogel Microneedles for Controlled Transdermal Drug Delivery. Acta Biomaterialia 2022, 153: 308-319.

[39] Kapoor DN, Bhatia A, Kaur R, Sharma R, Kaur G, Dhawan S: PLGA: A Unique Polymer for Drug Delivery. Therapeutic Delivery 2015, 6: 41-58.

[40] Dutta K, Das R, Ling J, Monibas RM, Carballo-Jane E, Kekec A, et al.: In Situ Forming Injectable Thermoresponsive Hydrogels for Controlled Delivery of Biomacromolecules. ACS Omega 2020, 5: 17531-17542.

[41] Trinh TA, Duy Le TM, Ho HGV, To TCT, Nguyen VVL, Huynh DP, et al.: A Novel Injectable pH-temperature Sensitive Hydrogel Containing Chitosan-insulin Electrosprayed Nanosphere Composite for an Insulin Delivery System in Type I Diabetes Treatment. Biomaterials Science 2020, 8: 3830-3843.

[42] Khaliq NU, Lee J, Kim S, Sung D, Kim H: Pluronic F-68 and F-127 Based Nanomedicines for Advancing Combination Cancer Therapy. Pharmaceutics 2023, 15: 2102.

[43] Chatterjee S, Hui PC, Wat E, Kan C-w, Leung P-C, Wang W: Drug Delivery System of Dual-responsive PF127 Hydrogel with Polysaccharide-based Nano-conjugate for Textile-based Transdermal Therapy. Carbohydrate Polymers 2020, 236: 116074.

[44] Mansoor S, Adeyemi SA, Kondiah PPD, Choonara YE: A Closed Loop Stimuli-responsive Concanavalin A-Loaded Chitosan-Pluronic Hydrogel for Glucose-Responsive Delivery of Short-Acting Insulin Prototyped in RIN-5F Pancreatic Cells. Biomedicines 2023, 11: 2545.

[45] Rangelov S, Simon P, Toncheva-Moncheva N, Dimitrov P, Gajewska B, Tsvetanov CB: Nanosized Colloidal Particles from Thermosensitive Poly(methoxydiethyleneglycol methacrylate)s in Aqueous Media. Polymer Bulletin 2012, 68: 2175-2185.

[46] Wu JZ, Williams GR, Li HY, Wang D, Wu H, Li SD, et al.: Glucose- and Temperature-sensitive Nanoparticles for Insulin Delivery. International Journal of Nanomedicine 2017, 12: 4037-4057.

[47] Saeed M, Elshaer A: Glucose-sensitive Materials for Delivery of Antidiabetic Drugs. Engineering Drug Delivery Systems 2020, 203-228.

[48] Yao Y, Ji K, Wang Y, Gu Z, Wang J: Materials and Carriers Development for Glucose-Responsive Insulin. Accounts of Materials Research 2022, 3: 960-970.

[49] Yu J, Zhang Y, Bomba H, Gu Z: Stimuli-responsive Delivery of Therapeutics for Diabetes Treatment. Bioengineering & Translational Medicine 2016, 1: 323-337.

[50] Santos Aguilar JGD: Applications of High-pressure Homogenization on Microbial Enzymes. Effect of High-Pressure Technologies on Enzymes 2023, 373-403.

[51] Bauer JA, Zámocká M, Majtán J, Bauerová-Hlinková V: Glucose Oxidase, an Enzyme “Ferrari”: Its Structure, Function, Production and Properties in the Light of Various Industrial and Biotechnological Applications. Biomolecules 2022, 12: 472.

[52] Moresi M, Parente E: Fermentation (Industrial) | Production of Some Organic Acids (Citric, Gluconic, Lactic, and Propionic). In Encyclopedia of Food Microbiology. 2nd edition. Edited by Batt CA, Tortorello ML. Oxford: Academic Press; 2014; 804-815.

[53] Ransy C, Vaz C, Lombès A, Bouillaud F: Use of H₂O₂ to Cause Oxidative Stress, the Catalase Issue. International Journal of Molecular Sciences 2020, 21: 9149.

[54] Kwon J, Kim J, Park S, Khang G, Kang PM, Lee D: Inflammation-Responsive Antioxidant Nanoparticles Based on a Polymeric Prodrug of Vanillin. Biomacromolecules 2013, 14: 1618-1626.

[55] Kim E-H, Chung D-Y, Park J-H, Yoo J-H: Dissolution of Oxalate Precipitate and Destruction of Oxalate Ion by Hydrogen Peroxide in Nitric Acid Solution. Journal of Nuclear Science and Technology 2000, 37: 601-607.

[56] Scott EA, Stano A, Gillard M, Maio-Liu AC, Swartz MA, Hubbell JA: Dendritic Cell Activation and T cell Priming with Adjuvant- and Antigen-loaded Oxidation-sensitive Polymersomes. Biomaterials 2012, 33: 6211-6219.

[57] Rehor A, Hubbell JA, Tirelli N: Oxidation-Sensitive Polymeric Nanoparticles. Langmuir 2005, 21: 411-417.

[58] Oide Y, Iwasaki M, Yoshida K, Sato K: Preparation of Multilayer Films Using the Negative Charge of Phenylboronic Acid and Its Response to pH Change, Fructose, and Hydrogen Peroxide. Colloid and Polymer Science 2018, 296: 1573-1580.

[59] Van Der Vlies AJ, Xu J, Ghasemi M, Bator C, Bell A, Rosoff-Verbit B, et al.: Thioether-based Polymeric Micelles with Fine-tuned Oxidation Sensitivities for Chemotherapeutic Drug Delivery. Biomacromolecules 2022, 23: 77-88.

[60] Pan Q, Deng X, Gao W, Chang J, Pu Y, He B: ROS Triggered Cleavage of Thioketal Moiety to Dissociate Prodrug Nanoparticles for Chemotherapy. Colloids and Surfaces B: Biointerfaces 2020, 194: 111223.

[61] Orian L, Flohé L: Selenium-Catalyzed Reduction of Hydroperoxides in Chemistry and Biology. Antioxidants 2021, 10: 1560.

[62] Cao W, Gu Y, Li T, Xu H: Ultra-sensitive ROS-responsive Tellurium-containing Polymers. Chemical Communication 2015, 51: 7069-7071.

[63] Loub J: The Oxides and Oxyacids of Tellurium. Collection of Czechoslovak Chemical Communications 1993, 58: 1717-1738.

[64] Everett SA, Swann E, Naylor MA, Stratford MR, Patel KB, Tian N, Newman RG, et al.: Modifying Rates of Reductive Elimination of Leaving Groups from Indolequinone Prodrugs: A Key Factor in Controlling Hypoxia-selective Drug Release. Biochemical Pharmacology 2002, 63: 1629-1639.

[65] Naylor MA, Swann E, Everett SA, Jaffar Mm Nolan J, Robertson N: Indolequinone Antitumor Agents: Reductive Activation and Elimination from (5-Methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl Derivatives and Hypoxia-selective Cytotoxicity In Vitro. Journal of Medicinal Chemistry 1998, 41: 2720-2731.

[66] Xia Y, Duan S, Han C, Jing C, Xiao Z, Li C: Hypoxia-responsive Nanomaterials for Tumor Imaging and Therapy. Frontiers in Oncology 2022, 12: 1089446.

[67] Yu J, Zhang Y, Ye Y, DiSanto R, Sun W, Ranson D, et al.: Microneedle-array Patches Loaded with Hypoxia-sensitive Vesicles Provide Fast Glucose-responsive Insulin Delivery. Proceedings of the National Academy of Sciences of the United States of America 2015, 112: 8260-8265.

[68] Jeon SI, Kim HJ, Lee JH, Ahn C-H: Development of a Hypoxia-Sensitive Material Producing Fluorescence and Ultrasound Signals. Macromolecular Research 2022, 30: 909-916.

[69] Filipczak N, Joshi U, Attia SA, Berger Fridman I, Cohen S, Konry T, et al.: Hypoxia-sensitive Drug Delivery to Tumors. Journal of Controlled Release 2022, 341: 431-442.

[70] Mashreghi M, Faal Maleki M, Askarizadeh A, Farshchi H, Farhoudi L, Nasrollahzadeh MS, et al.: A Novel and Easy to Prepare Azo-based Bioreductive Linker and Its Application in Hypoxia-sensitive Cationic Liposomal Doxorubicin: Synthesis, Characterization, In vitro and In vivo Studies in Mice Bearing C26 Tumor. Chemistry and Physics of Lipids 2022, 247: 105226.

[71] Le T-N, Lin C-J, Shen YC, Lin KY, Lee CK, Huang CC, et al.: Hyaluronic Acid Derived Hypoxia-Sensitive Nanocarrier for Tumor Targeted Drug Delivery. ACS Applied Bio Materials 2021, 4: 8325-8332.

[72] Galieva F, Khalifa M, Akhmetzyanova Z, Mironova D, Burilov V, Solovieva S, et al.: New Supramolecular Hypoxia-Sensitive Complexes Based on Azo-Thiacalixarene. Molecules 2023, 28: 466.

[73] Zhang J, Chen F, Yu D, Liang Z, Dai F, Liang H, et al.: Chitosan-based Injectable Hydrogels with Dual Glucose Sensors for Precise Control of Insulin Release and Diabetes Mellitus Therapy. International Journal of Pharmaceutics 2023, 643: 123246.

[74] Yu J, Qian C, Zhang Y, Cui Z, Zhu Y, Shen Q, et al.: Hypoxia and H₂O₂ Dual-Sensitive Vesicles for Enhanced Glucose-Responsive Insulin Delivery . Nano Letters 2017, 17: 733-739.

[75] Xu B, Jiang G, Yu W, Liu D, Zhang Y, Zhou J, et al.: H₂O₂-Responsive Mesoporous Silica Nanoparticles Integrated with Microneedle Patches for the Glucose-monitored Transdermal Delivery of Insulin . Journal of Materials Chemistry B 2017, 5: 8200-8208.

[76] Yang X-X, Feng P, Cao J, Liu W, Tang Y: Composition-engineered Metal-Organic Framework-Based Microneedles for Glucose-Mediated Transdermal Insulin Delivery. ACS Applied Materials & Interfaces 2020, 12: 13613-13621.

[77] Luo F-Q, Chen G, Xu W, Zhou D, Li J-X, Huang Y-C, et al.: Microneedle-array Patch with pH-sensitive Formulation for Glucose-responsive Insulin Delivery. Nano Research 2021, 14: 2689-2696.

[78] Ullah A, Choi HJ, Jang M, An S, Kim GM: Smart Microneedles with Porous Polymer Layer for Glucose-Responsive Insulin Delivery. Pharmaceutics 2020, 12: 606.

[79] CDC: National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States . National Statistic Report; 2020.

[80] Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL, On behalf of the IOF Bone and Diabetes Working Group: Mechanisms of Diabetes Mellitus-induced Bone Fragility. Nature Reviews. Endocrinology 2017, 13: 208-219.

[81] Hofbauer LC, Busse B, Eastell R, Ferrari S, Frost M, Müller R, et al.: Bone Fragility in Diabetes: Novel Concepts and Clinical Implications. The Lancet Diabetes & Endocrinology 2022, 10: 207-220.

[82] Dasari N, Jiang A, Skochdopole A, Chung J, Reece EM, Vorstenbosch J, et al.: Updates in Diabetic Wound Healing, Inflammation, and Scarring. Seminars in Plastic Surgery 2021, 35: 153-158.

[83] Gong Y, Gan Y, Wang P, Gong C, Han B, Li P, et al.: Injectable Foam-Like Scaffolds Release Glucose Oxidase-Integrated Metal-Organic Framework Hybrids for Diabetic Bone Defects. Applied Materials Today 2024, 38: 102190.

[84] Wu Y, Lyu Y, Li L, Zhou K, Cai J, Wang X, et al.: Unimolecular Cascaded Multienzyme Conjugates Modulate the Microenvironment of Diabetic Wound to Promote Healing. Biomacromolecules 2024, 25: 43-54.

[85] Hsu W-L, Huang C-Y, Hsu Y-P, Hwang T-L, Chang S-H, Wang H-YJ, et al.: On-skin Glucose-biosensing and On-demand Insulin-Zinc Hexamers Delivery Using Microneedles for Syringe-free Diabetes Management. Chemical Engineering Journal 2020, 398: 125536.

[86] Krautter F, Iqbal AJ: Glycans and Glycan-Binding Proteins as Regulators and Potential Targets in Leukocyte Recruitment. Frontiers in Cell and Developmental Biology 2021, 9: 624082.

[87] Taylor ME, Drickamer K, Imberty A, van Kooyk Y, Schnaar RL, Etzler ME, et al.: Discovery and Classification of Glycan-Binding Proteins. In Essentials of Glycobiology . 4th edition. Edited by Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, et al. NY: Cold Spring Harbor Laboratory Press; 2022 [http://www.ncbi.nlm.nih.gov/books/NBK579947/] Accessed on date 28 September 2024.

[88] Taylor ME, Drickamer K, Imberty A, van Kooyk Y, Schnaar RL, Etzler ME, et al.: Comparison of Two Major Classes of Glycan-Binding Proteins. In Essentials of Glycobiology . 4th edition. Edited by Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, et al.: Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2022. [https://www.ncbi.nlm.nih.gov/books/NBK579961/]. Accessed on date 28 September 2024.

[89] Bercea M, Lupu A: Recent Insights into Glucose-Responsive Concanavalin A-Based Smart Hydrogels for Controlled Insulin Delivery. Gels 2024, 10: 260.

[90] Sato K, Imoto Y, Sugama J, Seki S, Inoue H, Odagiri T, et al.: Sugar-Induced Disintegration of Layer-by-Layer Assemblies Composed of Concanavalin A and Glycogen. Langmuir 2005, 21: 797-799.

[91] Yin R, Wang K, Du S, Chen L, Nie J, Zhang W: Design of Genipin-crosslinked Microgels from Concanavalin A and Glucosyloxyethyl Acrylated Chitosan for Glucose-responsive Insulin Delivery. Carbohydrate Polymers 2014, 103: 369-376.

[92] Yin R, Wang K, Han J, Nie J: Photo-crosslinked Glucose-sensitive Hydrogels Based on Methacrylate Modified Dextran-concanavalin A and PEG Dimethacrylate. Carbohydrate Polymers 2010, 412-418.

[93] Yin R, Bai M, He J, Nie J, Zhang W: Concanavalin A-sugar Affinity Based System: Binding Interactions, Principle of Glucose-responsiveness, and Modulated Insulin Release for Diabetes Care. International Journal of Biological Macromolecules 2019, 124: 724-732.

[94] Bai M, He J, Kang L, Nie J, Yin R: Regulated Basal and Bolus Insulin Release from Glucose-Responsive Core-Shell Microspheres Based on Concanavalin A-Sugar Affinity. International Journal of Biological Macromolecules 2018, 889-899.

[95] Lin K, Yi J, Mao X, Wu H, Zhang LM, Yang L: Glucose-sensitive Hydrogels from Covalently Modified Carboxylated Pullulan and Concanavalin A for Smart Controlled Release of Insulin. Reactive and Functional Polymers 2019, 139: 112-119.

[96] Bai J, Zhang H, Yang Z, Li P, Liu B, Li D, et al.: On Demand Regulation of Blood Glucose Level by Biocompatible Oxidized Starch-Con A Nanogels for Glucose-responsive Release of Exenatide. Journal of Controlled Release 2022, 352: 673-684.

[97] Wang Y, Xing M, Cao Q, Ji A, Liang H, Song S: Biological Activities of Fucoidan and the Factors Mediating Its Therapeutic Effects: A Review of Recent Studies. Marine Drugs 2019, 17: 183.

[98] Zhou J, Ma H, Guan M, Feng J, Dong X, Wei Y, et al.: Anti-inflammatory Fucoidan-ConA Oral Insulin Nanosystems for Smart Blood Glucose Regulation. International Journal of Pharmaceutics 2024, 659: 124250.

[99] Aquinas N, Chithra CH, Bhat MR: Progress in Bioproduction, Characterization and Applications of Pullulan: A Review. Polymer Bulletin 2024, 81: 12347-12382.

[100] Govardhane S, Shende P: Phthalocyanine-based Glucose-responsive Nanocochleates for Dynamic Prevention of β-cell Damage in Diabetes. Journal of Liposome Research 2024, 34: 44-59.

[101] Wei H, Han L, Yin R, Yang T, Liu Y, Mou C, et al.: Micro-3D Printed Concanavalin A Hydrogel Based Photonic Devices for High-sensitivity Glucose Sensing. Sensors and Actuators B: Chemical 2023, 386: 133707.

[102] Yin R, Xin J, Yang D, Gao Y, Zhang H, Qian Z, et al.: High-Linearity Hydrogel-Based Capacitive Sensor Based on Con A-Sugar Affinity and Low-Melting-Point Metal. Polymers 2022, 14: 4302.

[103] Grams RJ, Santos WL, Scorei IR, Abad-García A, Rosenblum CA, Bita A, et al.: The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology. Chemical Reviews 2024, 124: 2441-2511.

[104] Das BC, Chokkalingam P, Masilamani P, Shukla S, Das S: Stimuli-Responsive Boron-Based Materials in Drug Delivery. International Journal of Molecular Sciences 2023, 24: 2757.

[105] Shiino D, Murata Y, Kataoka K, Koyama Y, Yokoyama M, Okano T: Preparation and Characterization of a Glucose-Responsive Insulin-releasing Polymer Device. Biomaterials 1994, 15: 121-128.

[106] Brooks WLA, Deng CC, Sumerlin BS: Structure-Reactivity Relationships in Boronic Acid-Diol Complexation. ACS Omega 2018, 3: 17863-17870.

[107] Yan J, Springsteen G, Deeter S, Wang B: The Relationship Among pK_a, pH, and Binding Constants in the Interactions between Boronic Acids and Diols-It is Not as Simple as It Appears . Tetrahedron 2004, 60: 11205-11209.

[108] Xu J, Zhang Y, Zhao S, Zhang J, Wang Y, Liu W, et al.: A Bioinspired Polymeric Membrane-enclosed Insulin Crystal Achieves Long-term, Self-regulated Drug Release for Type 1 Diabetes Therapy. Nature Nanotechnology 2025, 20: 697-706.

[109] Wang Y, Chen P, Liu W, Wei X, Zhang J, Wei X, et al.: Injectable Nanosized Formulation for Glucose-responsive Insulin Delivery. Nano Today 2023, 51: 101937.

[110] Sharmah B, Barman H, Uddin AN, Loying R, Kabir ME, Borah A, et al.: Surface-Functionalized Nanoceria: Dual Action in Diabetes Management Via Glucose-Responsive Insulin Delivery and Oxidative Stress Mitigation. ACS Biomaterials Science & Engineering 2024, 10: 6397-6414.

[111] Ji K, Wei X, Kahkoska AR, Zhang J, Zhang Y, Xu J, et al.: An Orally Administered Glucose-responsive Polymeric Complex for High-efficiency and Safe Delivery of Insulin in Mice and Pigs. Nature Nanotechnology 2024, 19: 1880-1891.

[112] Wang Y, Yu H, Wang L, Hu J, Feng J, Shen D, et al.: Microneedles with Two-Stage Glucose-Sensitive Controlled Release for Long-Term Insulin Delivery. ACS Biomaterials Science & Engineering 2023, 9: 2534-2544.

[113] Wu X, Li Z, Chen X-X, Fossey JS, James TD, Jiang YB: Selective Sensing of Saccharides Using Simple Boronic Acids and Their Aggregates. Chemical Society Reviews 2013, 42: 8032.

[114] Xiang Y, Xian S, Ollier RC, Yu S, Su B, Pramudya I, et al.: Diboronate Crosslinking: Introducing Glucose Specificity in Glucose-responsive Dynamic-covalent Networks. Journal of Controlled Release 2022, 348: 601-611.

[115] Xian S, VandenBerg MA, Xiang Y, Yu S, Webber MJ: Glucose-responsive Injectable Thermogels via Dynamic-covalent Cross-linking of Pluronic Micelles. ACS Biomaterials Science & Engineering 2022, 8: 4873-4885.

[116] Xian S, Xiang Y, Liu D, Fan B, Mitrová K, Ollier RC, et al.: Insulin-Dendrimer Nanocomplex for Multi-day Glucose-responsive Therapy in Mice and Swine. Advanced Materials 2024, 2308965.

[117] Liu X, Li C, Lv J, Huang F, An Y, Shi L, et al.: Glucose and H₂O₂ Dual-Responsive Polymeric Micelles for the Self-Regulated Release of Insulin . ACS Biomaterials Science & Engineering 2020, 3: 1598-1606.

[118] Li X, Pennington J, Stobaugh JF, Schöneich C: Synthesis of Sulfonamide- and Sulfonyl-phenylboronic Acid-modified Silica Phases for Boronate Affinity Chromatography at Physiological pH. Analytical Biochemistry 2008, 372: 227-236.

[119] Zhang P, Ma Q, He D, Liu G, Tang D, Liu L, et al.: A New Glucose-Responsive Delivery System Based on Sulfonamide-Phenylboronic Acid for Subcutaneous Insulin Injection. European Polymer Journal 2021, 157: 110648.

[120] Wang X, Huo H, Xu C, Lin H, Wang Q, Yang J, et al.: A Sensitive Non-enzymatic Dual-conductive Biosensor for Continuous Glucose Monitoring. Analytica Chimica Acta 2023, 1279: 341845.

[121] Osuna V, Aparicio Martínez EP, Dominguez RB, Rios AV: A Review on the Advances in Nanomaterials for Electrochemical Non-enzymatic Glucose Sensors Working in Physiological Conditions. Chemosensors 2024, 12: 159.

[122] Tong M-Q, Luo L-Z, Xue P-P, Han YH, Wang LF, Zhuge DL, et al.: Glucose-responsive Hydrogel Enhances the Preventive Effect of Insulin and Liraglutide on Diabetic Nephropathy of Rats. Acta Biomaterialia 2021, 122: 111-132.

[123] Ma Q, Bian L, Zhao X, Tian X, Yin H, Wang Y, et al.: Novel Glucose-responsive Nanoparticles Based on p-hydroxyphenethyl Anisate and 3-acrylamidophenylboronic acid Reduce Blood Glucose and Ameliorate Diabetic Nephropathy. Materials Today Bio 2022, 13: 100181.

[124] Hua S, Zhang Y, Zhu Y, Fu X, Meng L, Zhao L, et al.: Tunicate Cellulose Nanocrystals Strengthened Injectable Stretchable Hydrogel as Multi-responsive Enhanced Antibacterial Wound Dressing for Promoting Diabetic Wound Healing. Carbohydrate Polymers 2024, 343: 122426.

[125] Zhang S, Ge G, Qin Y, Li W, Dong J, Mei J, et al.: Recent Advances in Responsive Hydrogels for Diabetic Wound Healing. Materials Today Bio 2023, 18: 100508.

[126] Wang R, He X, Su S, Bai J, Xiang Q, Liu H, et al.: Advances in Smart Biomaterials that Modulate the Bone Microenvironment to Promote Bone Defect Repair in Diabetes Mellitus. Smart Materials in Medicine 2024, 5: 359-372.

[127] Liu Z, Mao J, Li W, Xu C, Lao A, Shin A, et al.: Smart Glucose-responsive Hydrogel with ROS Scavenging and Homeostasis Regulating Properties for Diabetic Bone Regeneration. Chemical Engineering Journal 2024, 497: 154433.

[128] Gupta H, Bhandari D, Sharma A: Recent Trends in Oral Drug Delivery: A Review. Recent Patents on Drug Delivery & Formulation 2009, 3: 162-173.

[129] Kaur G, Arora M, Ravi Kumar MNV: Oral Drug Delivery Technologies-A Decade of Developments. The Journal of Pharmacology and Experimental Therapeutics 2019, 370: 529-543.

[130] Drabczyk A, Kudłacik-Kramarczyk S, Jamroży M, Krzan M: Biomaterials in Drug Delivery: Advancements in Cancer and Diverse Therapies-Review. International Journal of Molecular Sciences 2024, 25: 3126.

[131] Eldor R, Francis BH, Fleming A, Neutel J, Homer K, Kidron M, et al.: Oral Insulin (ORMD-0801) in Type 2 Diabetes Mellitus: A Dose-finding 12-weeks Randomized Placebo-controlled Study. Diabetes Obesity Metabolism 2023, 25: 943-952.

[132] Smith F, Sabri AH, Heppel M, Fonseca I, Chowdhury F, Cheung K, et al.: The Clinical and Translational Prospects of Microneedle Devices, with a Focus on Insulin Therapy for Diabetes Mellitus as a Case Study. International Journal of Pharmaceutics 2022, 628: 122234.

[133] Chen R, Liu E, Fang Y, Gao N, Zhang M, Zhang X, et al.: Naturally Sourced Amphiphilic Peptides as Paclitaxel Vehicles for Breast Cancer Treatment. Biomaterials Advances 2024, 159: 213824.

[134] Sikder A, Chaudhuri A, Mondal S, Singh NDP: Recent Advances on Stimuli-Responsive Combination Therapy Against Multidrug-resistant Bacteria and Biofilm. ACS Applied Bio Materials 2021, 4: 4667-4683.

[135] Knipe JM, Chen F, Peppas NA: Enzymatic Biodegradation of Hydrogels for Protein Delivery Targeted to the Small Intestine. Biomacromolecules 2015, 16: 962-972.

[136] Averill-Bates D: Reactive Oxygen Species and Cell Signaling. Review. Biochimica et biophysica acta. Molecular Cell Research 2024, 1871: 119573.

[137] Son Y, Cheong Y-K, Kim N-H, Chung HT, Kang DG, Pae HO: Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways? Journal of Signal Transduction 2011, 2011: 792639.

[138] Wang X, Li S, Chen J, Liu L, Li F: Exogenous Alpha-Ketoglutaric Acid Alleviates the Rabbit Dermal Papilla Cell Oxidative Damage Caused by Hydrogen Peroxide Through the ERK/Nrf2 Signaling Pathway. Antioxidants 2025, 14: 455.

[139] Horowitz KM, Dorey A, Horowitz BZ: Severe Hypoglycemia and Hypothermia in Massive Metformin Overdose. Clinical Toxicology 2025, 63: 357-359.

[140] Jeremy T, George E, Cunliffe A: Hypoglycemia Secondary to Intentional Insulin Poisoning Managed With Intravenous Hydrocortisone. JCEM Case Reports 2025, 3: luaf041.

[141] Chen W, Yu S, Webber B, DeWolf EL, Kilmer R, Xian S, et al.: Supramolecular Peptide Depots for Glucose-Responsive Glucagon Delivery. Journal of Biomedical Materials Research Part A 2025, 113: e37854.

[142] D’souza AA, Shegokar R: Polyethylene Glycol (PEG): A Versatile Polymer for Pharmaceutical Applications. Expert Opinion on Drug Delivery 2016, 13: 1257-1275.

[143] Wang H, Wang Y, Yuan C, Xu X, Zhou W, Huang Y, et al.: Polyethylene glycol (PEG)-associated Immune Responses Triggered by Clinically Relevant Lipid Nanoparticles in Rats. NPJ Vaccines 2023, 8: 169.

[144] Aguado BA, Grim JC, Rosales AM, Watson-Capps JJ, Anseth KS: Engineering Precision Biomaterials for Personalized Medicine. Science Translational Medicine 2018, 10: eaam8645.

[145] Wang B, Siahaan T, Soltero R: Drug Delivery: Principles and Applications . Hoboken, NJ: Wiley-Interscience; 2005.

[146] Zamboni WC, Szebeni J, Kozlov SV, Lucas AT, Piscitelli JA, Dobrovolskaia MA, et al.: Animal Models for Analysis of Immunological Responses to Nanomaterials: Challenges and Considerations. Advanced Drug Delivery Reviews 2018, 136-137: 82-96.

[147] Shi D, Beasock D, Fessler A, Szebeni J, Ljubimova JY, Afonin KA, et al.: To PEGylate or Not to PEGylate: Immunological Properties of Nanomedicine’s Most Popular Component, Polyethylene Glycol and Its Alternatives. Advanced Drug Delivery Reviews 2022, 180: 114079.

[148] Salthouse D, Novakovic K, Hilkens CMU, Ferreira AM: Interplay Between Biomaterials and the Immune System: Challenges and Opportunities in Regenerative Medicine. Acta Biomaterialia 2023, 155: 1-18.

[149] Ju Y, Carreño JM, Simon V, Dawson K, Krammer F, Kent SJ: Impact of Anti-PEG Antibodies Induced by SARS-CoV-2 mRNA Vaccines. Nature Reviews. Immunology 2023, 23: 135-136.

[150] Guerrini G, Gioria S, Sauer AV, Lucchesi S, Montagnani F, Pastore G, et al.: Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-based COVID-19 Vaccine Administration. International Journal of Molecular Sciences 2022, 23: 8838.

[151] Mndlovu H, Kumar P, Du Toit LC, Choonara YE: A Review of Biomaterial Degradation Assessment Approaches Employed in the Biomedical Field. NPJ Materials Degradation 2024, 8: 66.

[152] Liu Y, Yang G, Jin S, Xu L, Zhao CX: Development of High-Drug-Loading Nanoparticles. ChemPlusChem 2020, 85: 2143-2157.

[153] Shen S, Wu Y, Liu Y, Wu D: High Drug-loading Nanomedicines: Progress, Current Status, and Prospects. International Journal of Nanomedicine 2017, 12: 4085-4109.

[154] Paliwal R, Babu RJ, Palakurthi S: Nanomedicine Scale-up Technologies: Feasibilities and Challenges. AAPS PharmSciTech 2014, 15: 1527-1534.

[155] Muthu MS, Wilson B: Challenges Posed by the Scale-up of Nanomedicines. Nanomedicine 2012, 7: 307-309.

[156] Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M: Scale-up Polymeric-based Nanoparticles Drug Delivery Systems: Development and Challenges. OpenNano 2022, 7: 100048.

[157] Kantak MN, Bharate SS: Analysis of Clinical Trials on Biomaterial and Therapeutic Applications of Chitosan: A Review. Carbohydrate Polymers 2022, 278: 118999.

[158] Namiot ED, Sokolov AV, Chubarev VN, Tarasov VV, Schiöth HB: Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines. International Journal of Molecular Sciences 2023, 24: 787.

[159] Lele M, Kapur S, Hargett S, Sureshbabu NM, Gaharwar AK: Global Trends in Clinical Trials Involving Engineered Biomaterials. Science Advances 2024, 10: eabq0997.

[160] New RRC, Ramanujam S, Chaudhari V, Bogus M, Travers GN, Namjoshi G: Safety and Efficacy of an Oral Insulin (Capsulin) in Patients with Early-Stage Type 2 Diabetes: A Dose-Ranging Phase IIb Study. Diabetes Obesity Metabolism 2023, 25: 953-960.

[161] Alshammari MK, Ghazwani JA, Alsharari FO, Alotaibi SS, Alotaibi RF, Alsayahani AA, et al.: An Update on Microneedle in Insulin Delivery: Quality Attributes, Clinical Status and Challenges for Clinical Translation. Journal of Drug Delivery Science and Technology 2022, 75: 103668.

[162] Zhao J, Xu G, Yao X, Zhou H, Lyu B, Pei S, et al.: Microneedle-based Insulin Transdermal Delivery System: Current Status and Translation Challenges. Drug Delivery and Translational Research 2022, 12: 2403-2427.

[163] Richardson T, Kerr D: Skin-Related Complications of Insulin Therapy: Epidemiology and Emerging Management Strategies. American Journal of Clinical Dermatology 2003, 4: 661-667.

[164] Du B, Ren X, Wang X, Wen Y, Yang J, Li L: Four-in-one pH/glucose-responsive Engineered Hydrogel for Diabetes Wound Healing. Nano Today 2025, 62: 102725.

[165] Wang G, Liao W, Han F, Shi Y, Hu Z: Advanced Biomaterials for Diabetes Healthcare and Complication Therapy: A Review. APL Materials 2024, 12: 110601.

[166] United State Food and Drug Authority (USFDA) . Nanotechnology Guidance Documents. FDA [https://www.fda.gov/science-research/nanotechnology-programs-fda/nanotechnology-guidance-documents] Accessed on date 3 October 2024.